On December 1, 2019, the United States Pharmacopoeia (USP) newly published chapter <60> Microbiological Examination of Non-Sterile Products Tests for Burkholderia Cepacia Complex became official as a means for testing drug components and/or final preparations for the presence of for Burkholderia Cepacia complex.

In this webinar, participants will have an opportunity to gain a strong understanding of the methodology to provide a presumptive identification based upon verification/qualification as well as the FDA and USP’s expectations.